Literature DB >> 20516169

Varenicline withdrawal-induced delirium with psychosis.

Alison C May, Demian Rose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20516169     DOI： 10.1176/appi.ajp.2010.09081194

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand.

Authors:  Mira Harrison-Woolrych; Janelle Ashton
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

2.  Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial.

Authors:  Gladys N Pachas; Corinne Cather; Sarah A Pratt; Bettina Hoeppner; Johanna Nino; Sara V Carlini; Eric D Achtyes; Harry Lando; Kim T Mueser; Nancy A Rigotti; Donald C Goff; A Eden Evins
Journal:  J Dual Diagn       Date:  2012-05-11

3.  Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats.

Authors:  Moe Igari; Jon C Alexander; Yue Ji; Xiaoli Qi; Roger L Papke; Adrie W Bruijnzeel
Journal:  Neuropsychopharmacology       Date:  2013-08-21       Impact factor: 7.853

4.  New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.

Authors:  Deniz Bagdas; Yasmin Alkhlaif; Asti Jackson; F Ivy Carroll; Joseph W Ditre; M Imad Damaj
Journal:  Neuropharmacology       Date:  2018-05-21       Impact factor: 5.250

5.  A Case Report on Varenicline Induced Delirium in an Alcohol and Nicotine Dependent Patient.

Authors:  A Lakshmi Narayan; H S Virupaksha; G Thejaswi; G R Saraswathy; V Madhavan; Murali Thyloth
Journal:  Indian J Psychol Med       Date:  2015 Jul-Sep

6.  Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis.

Authors:  Saeed Ahmed; Sanya Virani; Vijaya P Kotapati; Ramya Bachu; Mahwish Adnan; Ali M Khan; Aarij Zubair; Gulshan Begum; Jeevan Kumar; Mustafa Qureshi; Rizwan Ahmed
Journal:  Front Psychiatry       Date:  2018-09-19       Impact factor: 4.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.